Skip to main content
Log in

The Role of Pharmacokinetics in the Development of Biotechnologically Derived Agents

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Adolph EF. Quantitation relations in the physiological constitutions of mammals. Science 109: 579–585, 1949

    Article  PubMed  CAS  Google Scholar 

  • Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. In Meister (Ed.) Advances in enzymology, Vol. 41, pp. 99–128, Wiley & Sons, New York, 1974

    Google Scholar 

  • Banks WA, Kastin AJ, Barrera CM. Delivering peptides to the central nervous system: dilemmas and strategies. Pharmaceutical Research 8: 1345–1350, 1991

    Article  PubMed  CAS  Google Scholar 

  • Baumann G, Amburn KD, Buchanan TA. The effect of circulating growth hormone-binding protein on metabolic clearance, distribution and degradation of human growth hormone. Journal of Clinical Endocrinology and Metabolism 64: 657–660, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bocci V. Immunomodulators as local hormones: new insights regarding their clinical utilization. Journal of Biological Response Modifiers 4: 340–352, 1985

    PubMed  CAS  Google Scholar 

  • Bose S, Hickman J. Role of the carbohydrate moiety in determining the survival of interferon in the circulation. Journal of Biological Chemistry 252: 8336–8337, 1977

    PubMed  CAS  Google Scholar 

  • Boxenbaum H, D’Souza RW. Interspecies pharmacokinetic scaling, biological design, and neoteny. In Testa et al. (Eds) Advances in drug research, Vol. 19, pp. 139–196, Academic Press Limited, London, 1990

    Google Scholar 

  • Carone FA, Peterson DR, Flouret G. Renal tubular processing of small peptide hormones. Journal of Laboratory and Clinical Medicine 100: 1–14, 1982

    PubMed  CAS  Google Scholar 

  • Ceska JR, Berglund A, Lundkirst V, Grossmuller F. Influence of the degree of iodination and storage time on the immunological activity of 125I-IgE. Immunochemistry 9: 565–575, 1972

    Article  PubMed  CAS  Google Scholar 

  • Chappell WR, Mordenti J. Extrapolation of toxicological and pharmacological data from animals to humans. In Testa et al. (Eds) Advances in drug research, Vol. 20, pp. 1–116, Academic Press Limited, London, 1991

    Google Scholar 

  • Chen AB, Baker DL, Ferraiolo BL. Points to consider in correlating bioassays and immunoassays in the quantitation of peptides and proteins. In Garzone et al. (Eds) Peptides, peptoids and proteins, Vol. 3, pp. 53–71, Harvey Whitney Books, Cincinnati, 1991

    Google Scholar 

  • Daggett V. Protein degradation: the role of mixed-function oxidases. Pharmaceutical Research 4: 278–284, 1987

    Article  PubMed  CAS  Google Scholar 

  • Edwards NA. Scaling of renal functions in mammals. Comparative Biochemistry and Physiology 52A: 63–66, 1975

    Google Scholar 

  • Ferraiolo BL, Fuller GB, Burnett B, Chan E. Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous and subcutaneous administration. Journal of Biological Response Modifiers 7: 115–122, 1988

    PubMed  CAS  Google Scholar 

  • Ferraiolo BL, Winslow J, Laramee G, Celniker A, Johnston P. Pharmacokinetics and metabolism of human relaxins in rhesus monkeys. Pharmaceutical Research 8: 1032–1038, 1991

    Article  PubMed  CAS  Google Scholar 

  • Ferraiolo BL, Monier MA. Goals and analytical methodologies for protein disposition studies. In Ferraiolo et al. (Eds) Protein pharmacokinetics and metabolism, Plenum, New York, in press, 1992

    Google Scholar 

  • Firestone GL, Winguth SD. Immunoprecipitation of proteins. Methods of Enzymology 182: 688–699, 1990

    Article  CAS  Google Scholar 

  • Frohman LA, Downs TR, Williams TC, Heimer EP, Pan Y-CE, et al. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. Journal of Clinical Investigation 78: 906–913, 1986

    Article  PubMed  CAS  Google Scholar 

  • Fukuda MN, Sasaki H, Lopez L, Fukuda M. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 73: 84–89, 1989

    PubMed  CAS  Google Scholar 

  • Ghezzi P, Saccardo B, Bianchi M. Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochemistry Biophysics Research Communication 136: 316–321, 1986a

    Article  CAS  Google Scholar 

  • Ghezzi P, Saccardo B, Villa P, Rossi V, Bianchi M, et al. Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infectious Immunology 54: 837–840, 1986b

    CAS  Google Scholar 

  • Gosling JP. A decade of development of immunoassay methodology. Clinical Chemistry 36: 1408–1427, 1990

    PubMed  CAS  Google Scholar 

  • Harris R, Frade LG, Creighton LJ, Gascione PS, Alexandroni MM, et al. Investigation by HPLC of the catabolism of recombinant tissue plasminogen activator in the rat. Thrombosis and Haemotology 60: 107–112, 1988

    CAS  Google Scholar 

  • Havredaki M, Barona F. Variations in interferon inactivators and/or inhibitors in human serum and their relationship to interferon therapy. Japanese Journal of Medical Science and Biology 38: 107–111, 1985

    PubMed  CAS  Google Scholar 

  • Hindmarsh PC, Matthews DR, Brain CE, Pringle PJ, Di Silvio L, et al. The half-life of exogenous growth hormone after suppression of endogenous growth hormone secretion with somatostatin. Clinical Endocrinology 30: 443–450, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hulse JA, Rosenthal SM, Cuttler L, Kaplan SL, Grumbach MM. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men. Journal of Clinical Endocrinology and Metabolism 63: 872–878, 1986

    Article  PubMed  CAS  Google Scholar 

  • Jonkman JHG, Nicholson KH, Farrow PR, Eckert M, Grasmeijer G, et al. Effects of alfa-interferon on theophylline pharmacokinetics and metabolism. British Journal of Clinical Pharmacology 27: 795–802, 1989

    Article  PubMed  CAS  Google Scholar 

  • Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, et al. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Research 45: 2866–2872, 1985

    PubMed  CAS  Google Scholar 

  • LaBella FS, Geiger JD, Glavin GB. Administered peptides inhibit the degradation of endogenous peptides: the dilemma of distinguishing direct from indirect effects. Peptides 6: 645–660, 1985

    Article  PubMed  CAS  Google Scholar 

  • LaRusso NF. Proteins in bile: how they get there and what they do. American Journal of Physiology 247: G199–G205, 1984

    PubMed  CAS  Google Scholar 

  • Lelchuk R, Playfair JHL. Serum IL-2 inhibitor in mice I: increase during infection. Immunology 56: 113–118, 1985

    PubMed  CAS  Google Scholar 

  • Lochs H, Williams PE, Morse EL, Abumrad NN, Adibi SA. Metabolism of dipeptides and their constituent amino acids by liver, gut, kidney, and muscle. American Journal of Physiology 254: E588–E594, 1988

    PubMed  CAS  Google Scholar 

  • Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport and metabolism of low-molecular-weight proteins: a review. Kidney International 16: 251–270, 1979

    Article  PubMed  CAS  Google Scholar 

  • MacNamara EM, Whicher JT. Electrophoresis and densitometry of serum and urine in the investigation and significance of monoclonal immunoglobulins. Electrophoresis 11: 376–381, 1990

    Article  PubMed  CAS  Google Scholar 

  • Matsas R, Kenny AJ, Turner AJ. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochemical Journal 223: 433–440, 1984

    PubMed  CAS  Google Scholar 

  • Matsuyama H, Ruhmann-Wennhold A, Johnson LR, Nelson DH. Disappearance rates of exogenous and endogenous ACTH from rat plasma measured by bioassay and radioimmunoassay. Metabolism 21: 30–35, 1972

    Article  PubMed  CAS  Google Scholar 

  • McMartin C. Pharmacokinetics of peptides and proteins; opportunities and challenges. Advanced Drug Research 22: 39–106, 1992

    CAS  Google Scholar 

  • Mohler MA, Cook J, Baumann G. Binding proteins of protein therapeutics. In Ferraiolo et al. (Eds) Protein pharmacokinetics and metabolism, Plenum, New York, in press, 1992

    Google Scholar 

  • Mordenti J, Chen SA, Moore JA, Ferraiolo BL, Green JD. Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharmaceutical Research 8: 1351–1359, 1991

    Article  PubMed  CAS  Google Scholar 

  • Nadeau RW, Oldfield NF, Garland WA, Liberato DJ. Quatification of recombinant interleukin-2 in human serum by a specific immunobioassay. Analytical Chemistry 61: 1732–1736, 1989

    Article  PubMed  CAS  Google Scholar 

  • Nadeau RW, Satoh H, Scheide S, Crowl R, Conroy R, et al. A comparison of mass balance, pharmacokinetics and disposition of 125I and 14C recombinant human interleukin-2 (rhIl-2) in cynomolgus monkeys. Drug Metabolism and Disposition, in press, 1992

    Google Scholar 

  • Nokta M, Loh JP, Douidar SM, Ahmed AE, Pollard RB. Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients. Journal of Interferon Research 11: 159–164, 1991

    Article  PubMed  CAS  Google Scholar 

  • Parkinson A, Lasker J, Kramer MJ, Huang M-T, Thomas PE, et al. Effects of three recombinant human leukocyte interferons on drug metabolism in mice. Drug Metabolism and Disposition 10: 579–585, 1982

    PubMed  CAS  Google Scholar 

  • Philips TM. Isolation and recovery of biologically active proteins by high performance immunoaffinity chromatography. In Kerlavage (Ed.) The use of HPLC in receptor biochemistry, pp. 129–154, Alan R. Liss, New York, 1989

    Google Scholar 

  • Quiron R. Bioassays in modern peptide research. Peptides 3: 223–230, 1982

    Article  Google Scholar 

  • Regoeczi E (Ed.) Iodine-labelled plasma proteins, Vol. 2 Part A, pp. 6, 112, 116–117, CRC Press, Boca Raton, 1987a

    Google Scholar 

  • Regoeczi E (Ed.) Iodine-labelled plasma proteins, Vol. 2 Part B, pp. 43–62, CRC Press, Boca Raton, 1987b

    Google Scholar 

  • Rochiccioli PE, Tauber MT, Coude FX, Arone M, Morre M, et al. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24h GH secretion in six children with partial GH deficiency. Journal of Clinical Endocrinology and Metabolism 65: 268–274, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rosa C, Amr S, Birken S, Wehmann R, Nisula B. Effect of desialylation of human chorionic gonadotropin on its metabolic clearance rate in humans. Journal of Clinical Endocrinology and Metabolism 59: 1215–1219, 1984

    Article  PubMed  CAS  Google Scholar 

  • Ross RJM, Rodda C, Tsagarakis S, Davies PSW, Grossman A, et al. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone. Lancet 1: 5–8, 1987

    Article  PubMed  CAS  Google Scholar 

  • Stahl WR. Scaling of respiratory variables in mammals. Journal of Applied Physiology 22: 453–460, 1967

    PubMed  CAS  Google Scholar 

  • Sugiyama Y, Hanano M. Receptor-mediated transport of peptide hormones and its importance in the overall disposition in the body. Pharmaceutical Research 6: 192–202, 1989

    Article  PubMed  CAS  Google Scholar 

  • Taylor G, Marafino BJ, Moore JA, Gurley V, Blaschke JF. Interferon reduces hepatic drug metabolism in vivo in mice. Drug Metabolism and Disposition 13: 459–463, 1985

    PubMed  CAS  Google Scholar 

  • Timmons TM, Dunbar BS. Protein blotting and immunodetection. Methods in Enzymology 182: 679–688, 1990

    Article  PubMed  CAS  Google Scholar 

  • Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, et al. Pulsatile growth hormone secretion in normal men during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Journal of Clinical Investigation 75: 1584–1590, 1985

    Article  PubMed  CAS  Google Scholar 

  • Von Wussow P, Borden EC. Antibodies to interferons in patients: defining their significance. Journal of Interferon Research 9 (Suppl. 1): 51–572, 1989

    Google Scholar 

  • Waldhausl WK, Bratusch-Marrain PR, Vierhapper H, Nowotny P. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism 32: 478–486, 1983

    Article  PubMed  CAS  Google Scholar 

  • Williams SJ, Farrell GC. Inhibition of antipyrine metabolism by interferon. British Journal of Clinical Pharmacology 22: 610–612, 1986

    Article  PubMed  CAS  Google Scholar 

  • Williams SJ, Baird-Lambert JA, Farrell GC. Inhibition of theophylline metabolism by interferon. Lancet 2: 939–941, 1987

    Article  PubMed  CAS  Google Scholar 

  • Wills RJ, Dennis SA, Spiegel HE, Gibson DM, Nadler PI. Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection. Clinical Pharmacology and Therapeutics 35: 722–727, 1984

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wills, R.J., Ferraiolo, B.L. The Role of Pharmacokinetics in the Development of Biotechnologically Derived Agents. Clin. Pharmacokinet. 23, 406–414 (1992). https://doi.org/10.2165/00003088-199223060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199223060-00002

Keywords

Navigation